Geode Capital Management, LLC Allovir, Inc. Transaction History

Geode Capital Management, LLC

$1.21 Trillion
Q3 2024

A detailed history of Geode Capital Management, LLC transactions in Allovir, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 585,548 shares of ALVR stock, worth $275,207. This represents 0.0% of its overall portfolio holdings.

Number of Shares

585,548

Previous 647,477 9.56%

Holding current value

$275,207

Previous $466,000 1.72%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$0.7 - $0.82 $43,350 - $50,781	-61,929 Reduced 9.56%	585,548 $474,000
Q2 2024 Aug 09, 2024	SELL	$0.72 - $0.82 $451,040 - $513,684	-626,445 Reduced 49.17%	647,477 $466,000
Q1 2024 May 13, 2024	BUY	$0.64 - $0.78 $13,237 - $16,133	20,684 Added 1.65%	1,273,922 $968,000
Q4 2023 Feb 13, 2024	BUY	$0.68 - $2.39 $50,317 - $176,852	73,997 Added 6.27%	1,253,238 $852,000
Q3 2023 Nov 13, 2023	BUY	$2.15 - $3.64 $550,034 - $931,221	255,830 Added 27.7%	1,179,241 $2.54 Million
Q2 2023 Aug 11, 2023	BUY	$3.17 - $5.82 $420,782 - $772,540	132,739 Added 16.79%	923,411 $3.14 Million
Q1 2023 May 15, 2023	BUY	$3.94 - $7.05 $112,955 - $202,116	28,669 Added 3.76%	790,672 $3.12 Million
Q4 2022 Feb 13, 2023	BUY	$4.7 - $9.98 $34,013 - $72,225	7,237 Added 0.96%	762,003 $3.91 Million
Q3 2022 Nov 14, 2022	BUY	$4.13 - $8.79 $841,326 - $1.79 Million	203,711 Added 36.97%	754,766 $5.96 Million
Q2 2022 Aug 12, 2022	BUY	$3.26 - $7.06 $3,338 - $7,229	1,024 Added 0.19%	551,055 $2.15 Million
Q1 2022 May 13, 2022	BUY	$6.75 - $13.52 $80,176 - $160,590	11,878 Added 2.21%	550,031 $3.71 Million
Q4 2021 Feb 11, 2022	BUY	$12.94 - $25.99 $310,430 - $623,500	23,990 Added 4.67%	538,153 $6.96 Million
Q3 2021 Nov 12, 2021	BUY	$16.97 - $25.06 $1.4 Million - $2.07 Million	82,580 Added 19.13%	514,163 $12.9 Million
Q2 2021 Aug 13, 2021	BUY	$19.44 - $25.06 $77,740 - $100,214	3,999 Added 0.94%	431,583 $8.52 Million
Q1 2021 May 12, 2021	BUY	$20.81 - $45.5 $2.45 Million - $5.36 Million	117,711 Added 37.99%	427,584 $10 Million
Q4 2020 Feb 12, 2021	BUY	$23.94 - $46.81 $262,214 - $512,709	10,953 Added 3.66%	309,873 $11.9 Million
Q3 2020 Nov 13, 2020	BUY	$21.05 - $42.7 $6.29 Million - $12.8 Million	298,920 New	298,920 $8.22 Million

Others Institutions Holding ALVR

# of Institutions

Shares Held

44.6M

Call Options Held

14.9K

Put Options Held

200

View Full List

About Allovir, Inc.

Ticker ALVR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,063,400
Market Cap $43.7M
Description
Allovir, Inc., a clinical-stage cell therapy company, engages in the research and development of allogeneic, off-the-shelf multi-virus specific T cell (VST) therapies to prevent and treat devastating viral-associated diseases. The company's lead product is posoleucel, an allogeneic, off-the-shelf VST therapy, to treat BK virus, cytomegalovirus, ...

More about ALVR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Allovir, Inc. Transaction History